Exploring Third-Line Options in HER2+ mBC: Janet’s Case & Key Trial Insights from HER2CLIMB and EMILIA

Dr O’Shaughnessy leads a panel of medical experts in a discussion around a patient case surrounding findings from HER2CLIMB and EMILIA clinical trials.

EP: 1.Treatment Selection and Sequencing in Third Line Settings and Beyond

EP: 2.Understanding Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

Now Viewing

EP: 3.Exploring Third-Line Options in HER2+ mBC: Janet’s Case & Key Trial Insights from HER2CLIMB and EMILIA

Video content above is prompted by the following:

• Please explore key clinical trial data findings, emphasizing perspectives around clinical safety and efficacy.

Recent Videos